Danazol is a key drug for the treatment of specific diseases, and the standardization and accessibility of its purchase channels directly affect the continuity of treatment for patients. Clarifying the compliant drug purchase path is an important prerequisite for ensuring drug safety and maintaining treatment efficacy.

Danazol compliant purchase channels

According to the drug administration regulations, Danazol must be sold through formal medical institutions or retail pharmacies with a "Drug Business License". Patients can obtain drugs through hospital outpatient pharmacies, designated medical insurance pharmacies and certified online pharmaceutical platforms (with Internet drug transaction service qualification certificates), and it is strictly forbidden to purchase drugs through informal channels such as personal purchasing agents and overseas direct mail.

When using Danazol(Danocrine) clinically, be cautious when using it in combination with other drugs. This is because the metabolism and efficacy of Danazol in the body may be affected by other drugs, resulting in increased or weakened efficacy, and may even trigger new adverse reactions, potentially affecting the patient's treatment efficacy.

Description of R&D vendor association

Danazol manufacturers build distribution networks through authorized distributors, provincial pharmaceutical companies directly supply to medical institutions as primary distributors, and secondary distributors are only allowed to supply to chain pharmacies. Patients can check the list of designated distributors through the manufacturer's official website to avoid purchasing expired or repackaged drugs through unauthorized channels.

Drug Interactions with Danocrine?

Drug interaction refers to the simultaneous use of two or more drugs, due to the interaction between drugs, which may lead to the enhancement or weakening of the drug effect, and may also produce new therapeutic effects or adverse reactions.

Warfarin

Prolonged prothrombin time in patients who are stable on warfarin.

Carbamazepine

In patients taking both Danazol and carbamazepine, treatment with Danazol may result in increased levels of carbamazepine.

Anti-diabetic drugs

Danazol can cause insulin resistance. Caution should be exercised when using in combination with antidiabetic drugs.

Cyclosporine and tacrolimus

Danazol may elevate plasma levels of cyclosporine and tacrolimus, leading to increased nephrotoxicity with these drugs. Patients taking cyclosporine and tacrolimus with Danazol may need to monitor systemic concentrations of these drugs and adjust doses appropriately.

Synthetic vitamin D analogues

Danazol increases the serum calcium response to synthetic vitamin D analogues in patients with primary hypoparathyroidism.

Statins

Concomitant use of Danazol with statins (such as simvastatin, atorvastatin, and lovastatin) increases the risk of myopathy and rhabdomyolysis. If patients need to use it concurrently, they should be cautious and consult the product label of the statin for specific information on dose restrictions when using Danazol.

During treatment with Danazol, patients should take the initiative to inform their doctor of all the drugs they are taking, including prescription drugs, over-the-counter drugs, and herbal medicines, so that doctors can fully evaluate the patient's medication and formulate a more reasonable treatment plan.

Drug interaction is a non-negligible part of the treatment of Danazol, when patients use Danazol for treatment, please strictly follow the doctor's guidance for medication, avoid blindly using other drugs, and do not adjust the dosage of Danazol treatment.